http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BD to Announce Financial Results for its First Quarter of Fiscal 2026
-
BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business
-
BD launches AI-powered tool for flow cytometry research automation
-
BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation
-
BD and Ypsomed develop 5.5ml syringe for large-volume biologics
-
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market
-
BD gains FDA clearance for multi-modality breast biopsy system
-
BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System
-
BD invests $110 million in Nebraska prefillable syringe production
-
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs
-
BD To Host Virtual 2026 Annual Meeting of Shareholders
-
BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial
-
BD partners with Penn institute for immunotherapy research study
-
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry
-
BD adds two diagnostic assays to European portfolio
-
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec
-
BD partners with ChemoGLO to expand hazardous drug testing services
-
BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories
-
BD launches three and four-laser cell analyzer configurations
-
BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes
-
BD launches Surgiphor wound irrigation system in Europe
-
BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety
-
BD appoints two directors with healthcare and technology expertise
-
BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors
-
BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification
-
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH
-
BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go
-
BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
-
BD Board Increases Dividend for 54th Consecutive Year
-
BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease
-
BD receives FDA clearance for bacterial diagnostic panels
-
BD Receives FDA 510(k) Clearance and CE-IVDR Certification for High-Throughput Enteric Bacterial Panels on BD COR™ System
-
BD launches at-home HPV testing solution for markets outside US
-
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
-
BD launches AI-enabled platform for healthcare device connectivity
-
BD Launches New AI-enabled Solutions to Drive Connectivity Across Healthcare Settings
-
BD marks 65 years at Nebraska facility, invests over $50 million since 2020
-
BD Looks Ahead to the Next Era of Manufacturing Excellence in Broken Bow, NE and Celebrates 65 Years of Innovation in the Region
-
BD names interim CFO as DelOrefice departs in December
-
BD Announces CFO Transition Plan
-
BD to Announce Financial Results for its Fourth Quarter and Full Year of Fiscal 2025
-
BD enrolls first patient in registry study for artery disease device
-
BD Reaches Major Milestone for Rotarex™ Catheter System with First Patient Enrolled in XTRACT™ Registry to Advance Real-World Evidence in Peripheral Artery Disease
-
BD partners with Opentrons to automate single-cell analysis instruments
-
BD and Opentrons Collaborate to Accelerate Single-Cell Multiomics Discoveries with Robotic Automation
-
BD Celebrates 55 Years of Manufacturing Excellence and Impact in Sumter, S.C.
-
BD partners with Henry Ford Health on pharmacy automation system
-
BD and Henry Ford Health Sign Pharmacy Automation Partnership to Revolutionize Medication Storage and Prescription Delivery
-
BD Marks 1,000th BD Rhapsody System, Driving Scientific Breakthroughs via Single-Cell Multiomics
-
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative
